Clinical Trial Update: Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update details a Phase 2 study evaluating ultralow-dose PET imaging of SSTR2 radiotracer uptake, with participants including healthy con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• SSTR2 radiotracer

Snippet

Sponsor: Akiva Mintz | Conditions: Healthy (Controls), Healthy Volunteers | Phase 2 | Status: RECRUITING